Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host

By sjmartinez • January 5, 2024

Winston DJ, Young PA, Schlamm HT, Schiller GJ. Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host. Clin Infect Dis. 2024 Jan 4:ciad769. doi: 10.1093/cid/ciad769. Epub ahead of print. PMID: 38174352.

Tags: Hematology/Oncology, Publications

Related Posts

Feasibility of cognitive testing and ecological momentary assessments using smartphones in middle aged and older adults with insomnia

Ghadimi S, Ereso J, Kaula AJ, Taptiklis N, Cormack F, Alessi C, Martin JL, Dzierzewski JM, Naeim A, Kremen S, Te T, Fung CH. Feasibility[...]

A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO

Hardesty MM, Krivak TC, Wright GS, Hamilton E, Fleming EL, Belotte J, Gorman S, Compton N, Clements A, Gray HJ, Konecny GE, Moore RG, Richardson[...]

A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastoma

Amaral LJ, Gresham G, Kim S, Tighiouart M, Nelson TA, Welborn A, Lockshon L, Noorvash B, Rudnick JD, Irwin SA, Freedland SJ, Hu J. A[...]